CHOP chemotherapy plus rituximab compared with CHOP alone in diffuse large B-cell lymphoma patients

被引：0
|
作者：
Poddubnaya, I [1 ]
Osmanov, D [1 ]
Babicheva, L [1 ]
Falaleeva, N [1 ]
机构：
[1] NN Blokhin Canc Res Ctr, Moscow, Russia
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
478
引用
收藏
页码：177 / 177
页数：1
相关论文
共 50 条
  • [21] Subcutaneous Compared to Intravenous Administration of Rituximab Plus CHOP in Patients with Diffuse Large B-Cell Lymphoma a Study By the Polish Lymphoma Research Group
    Paszkiewicz-Kozik, Ewa
    Dlugosz-Danecka, Monika
    Robak, Pawel J.
    Wojciechowska-Lampka, Elzbieta
    Swierkowska-Czeneszew, Monika
    Tajer, Joanna
    Romejko-Jarosinska, Joanna
    Domanska-Czyz, Katarzyna
    Szymanski, Marcin
    Morawska, Marta
    Targonski, Lukasz
    Osowiecki, Michal
    Ostrowska, Beata
    Dabrowska-Iwanicka, Anna Paulina
    Walewski, Jan
    BLOOD, 2017, 130
  • [22] R-CHOP compared with CHOP in patients with diffuse large B-cell lymphoma (DLCL): Russian experience
    Poddubnaya, I.
    Osmanov, E.
    Babicheva, L.
    Tumyan, G.
    Sorokin, E.
    Stefanov, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] Irinotecan plus cisplatin and dexamethasone (ICD) combination chemotherapy for patients with diffuse large B-cell lymphoma previously treated with Rituximab plus CHOP
    Kang, Hye Jin
    Kim, Won Seog
    Suh, Cheolwon
    Park, Yeon Hee
    Kim, Bong Seog
    Yuh, Young Jin
    Ryoo, Baek-Yeol
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (02) : 299 - 304
  • [24] Modified CHOP-chemotherapy plus Rituximab for diffuse large B-cell lymphoma complicating ataxia-telangiectasia
    Rossi, G
    Zecca, M
    Marchi, A
    De Stefano, P
    Sammarchi, L
    Locatelli, F
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (02) : 369 - 371
  • [25] Irinotecan plus cisplatin and dexamethasone (ICD) combination chemotherapy for patients with diffuse large B-cell lymphoma previously treated with Rituximab plus CHOP
    Hye Jin Kang
    Won Seog Kim
    Cheolwon Suh
    Yeon Hee Park
    Bong Seog Kim
    Young Jin Yuh
    Baek-Yeol Ryoo
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 299 - 304
  • [26] Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)
    Mounier, N
    Briere, J
    Gisselbrecht, C
    Emile, JF
    Lederlin, P
    Sebban, C
    Berger, F
    Bosly, A
    Morel, P
    Tilly, H
    Bouabdallah, R
    Reyes, F
    Gaulard, P
    Coiffier, B
    BLOOD, 2003, 101 (11) : 4279 - 4284
  • [27] Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Chinese patients
    J. M. Li
    L. Wang
    Y. Shen
    Z. G. Xia
    Y. Chen
    Q. S. Chen
    Y. Chen
    X. Y. Zeng
    J. H. You
    Y. Qian
    Z. X. Shen
    Annals of Hematology, 2007, 86 : 639 - 645
  • [28] Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Chinese patients
    Li, J. M.
    Wang, L.
    Shen, Y.
    Xia, Z. G.
    Chen, Y.
    Chen, Q. S.
    Chen, Y.
    Zeng, X. Y.
    You, J. H.
    Qian, Y.
    Shen, Z. X.
    ANNALS OF HEMATOLOGY, 2007, 86 (09) : 639 - 645
  • [29] Rituximab CHOP for successful management of diffuse large B-cell lymphoma of the ovary
    Ahbeddou, Nawal
    Fetohi, Mohamed
    El Khanoussi, Basma
    Errihani, Hassan
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2011, 283 (05) : 1173 - 1174
  • [30] Rituximab CHOP for successful management of diffuse large B-cell lymphoma of the ovary
    Nawal Ahbeddou
    Mohamed Fetohi
    Basma El Khanoussi
    Hassan Errihani
    Archives of Gynecology and Obstetrics, 2011, 283 : 1173 - 1174
12345